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A B S T R A C T
In the present investigation we report the antibacterial activity of halistanol sulfate A iso-
lated from the sponge Petromica ciocalyptoides, as well as of rodriguesines A and B isolated 
from the ascidian Didemnum sp., against the caries etiologic agent Streptococcus mutans. The 
transcription levels of S. mutans virulence genes gtfB, gtfC and gbpB, as well as of house-
keeping genes groEL and 16S, were evaluated by sqRT-PCR analysis of S. mutans planktonic 
cells. There were no alterations in the expression levels of groEL and 16S after antimicrobial 
treatment with halistanol sulfate A and with rodriguesines A and B, but the expression of 
the genes gtfB, gtfC and gbpB was down-regulated. Halistanol sulfate A displayed the most 
potent antimicrobial effect against S. mutans, with inhibition of biofilm formation and re-
duction of biofilm-associated gene expression in planktonic cells. Halistanol sulfate A also 
inhibited the initial oral bacteria colonizers, such as Streptococcus sanguinis, but at much 
higher concentrations. The results obtained indicate that halistanol sulfate A may be con-
sidered a potential scaffold for drug development in Streptococcus mutans antibiofilm thera-
py, the main etiologic agent of human dental caries.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
Introduction
Caries is an infectious disease caused by the accumulation of 
biofilm on the tooth surface. Streptococcus mutans is considered 
the main etiologic agent of human dental caries (Whiley and 
Beighton, 1998). S. mutans can metabolize diet carbohydrates, 
producing high levels of water-insoluble glucan matrixes from 
sucrose, which are responsible for the initial stage of oral 
biofilm formation. S. mutans expresses several virulence genes 
that regulate its growth and accumulation on tooth surfaces, 
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promoting acid-mediated tooth demineralization and acid 
tolerance. S. mutans is adapted to the biofilm lifestyle, which 
is essential for the pathogenesis of dental caries (Stipp et al., 
2008).
One of the strategies for preventing the formation and 
development of dental caries is to control the growth and 
adherence of mutans streptococci on the dental surface (Smith, 
2002) by inhibiting cell-cell signaling (Lonn-Stensrud et al., 
2007) and/or acid production. Several S. mutans virulence genes 
and corresponding functions have been identified. For example, 
glucosyltransferases GtfB and GtfC catalyze the extracellular 
synthesis of a water-insoluble glucan matrix from sucrose, and 
are essential for the accumulation of bacteria in the dental 
biofilm. GbpB (Glucan Binding Proteins), an essential protein of S. 
mutans, might also mediate cell surface interaction with glucan, 
increasing the adherence ability of the bacterial pathogen in 
the dental biofilm (Mattos-Graner et al., 2001). Inhibitors of 
these virulence factors represent important candidates for 
antibiofilm therapy. 
Fluoride, chlorhexidine and their combinations have been 
used to control dental caries (Bader et al., 2001). Additionally, 
natural product-based treatments, such as propolis and plant 
extracts, have been successfully used against dental caries (Koo 
et al., 2000, 2006; Galvão et al., 2012). Examples of anticariogenic 
natural products include anthraquinones, apigenin, 
tt-farnesol, chitosan, 7-epiclusianone, 2-aminoimidazole 
and 2-aminobenzimidazole, several of which have shown 
antibiofilm activity against Streptococcus mutans (Koo et al., 
2003; Coenye et al., 2007; Murata et al., 2008; Pasquantonio et 
al., 2008; Liu et al., 2011). However, very few natural products 
isolated from marine organisms have been evaluated as 
inhibitors of bacterial oral pathogens.
Marine natural products isolated from invertebrates, 
such as sponges, ascidians, octocorals and bryozoans, as 
well as from associated microorganisms, such as bacteria, 
fungi, cyanobacteria and dinoflagellates, are considered 
very promising sources of new drug candidates, including 
antibiotics (Seleghim et al., 2007; Liu et al., 2011; Mai et al., 
2011; Kossuga et al., 2012; Mayer et al., 2013; Butler et al., 2014; 
Blunt et al., 2014).
The aim of this investigation was to evaluate the 
antimicrobial activity of halistanol sulfate A and of 
rodriguesines A and B against three species of oral bacterial 
and three species of pathogens. The same compounds were 
further evaluated for their effect on the transcription levels 
of known biofilm-associated genes, including gtfB, gtfC and 
gbpB, of two Streptococcus mutans strains. In addition, the 
transcription levels of groEL and 16S genes were also evaluated 
on Streptococcus mutans. 
Material and methods 
Isolation of halistanol sulfate A and of rodriguesines A and B 
Halistanol sulfate A (1) was obtained from the sponge Petromica 
ciocalyptoides as previously described (Kossuga et al., 2007). 
Rodriguesines A (2) and B (3) were obtained from an ascidian of 
the genus Didemnum as an inseparable mixture of homologues, 
as previously described (Kossuga et al., 2009) and tested as 
such. Both halistanol sulfate A and rodriguesines A and B have 
been identified by a complete analysis of spectroscopic data, as 
previously reported (Kossuga et al., 2007, Kossuga et al., 2009).
 
Microorganisms
Pure compounds obtained from marine organisms were 
tested against Streptococcus mutans UA 159, Streptococcus 
mutans CI (clinical isolate), Streptococcus sanguinis ATCC 15300, 
Streptococcus sobrinus ATCC 27607, Staphylococcus aureus ATCC 
6538, Enterococcus faecalis ATCC 14506 and Escherichia coli NCTC 
8196. Streptococcus mutans CI was isolated from an active caries 
individual, as previously described (Klein et al., 2004).
Antimicrobial assays
The minimal inhibitory concentration (MIC) test or broth 
microdilution assay was carried out using microplates (96 
wells), following the procedure described by Oliveira et al. 
(2006), with modifications. Aliquots of pure compounds 
were diluted in 1% (v/v) dimethylsulfoxide (DMSO - 1250 μg/
ml). Serial dilutions of antimicrobial agents were prepared 
in 80 μl of BHI (Brain Heart Infusion) medium, and 20 μl of 
bacterial suspension (approximately 1 × 108 CFU/ml) were 
added to the wells containing different final concentrations 
of the antimicrobial agents ranging from 0.05 to 500 μg/ml, at 
a final volume of 100 μl/well. Microplates were incubated at 
37°C and 10% CO2 for 24 h. The bacterial growth was measured 
by absorbance at OD550-560 nm in an automated microplate 
reader (Molecular Devices, Versa Max Program). The MIC values 
were defined as the lowest antimicrobial concentration that 
inhibited 90 to 100% of bacterial growth compared to a positive 
control. Microbial cultures grown in medium (1% DMSO v/v) 
without antimicrobial samples and with doxycycline (0.05 
to 5 μg/ml) were used as the negative and positive controls, 
respectively. All samples were assayed in triplicate.
To determine the minimal bactericidal concentration 
(MBC) of the tested samples, an aliquot of each sample in 
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concentrations ≥ MIC was inoculated on BHA medium. The 
plates were incubated at 37°C and 10% CO2 for 24 to 48 h. The 
MBC values were defined as the lowest concentration of a pure 
compound that promoted no visible bacterial growth in the 
tested medium. To determine the nature of the antibacterial 
effect of the samples, the bacterial MBC/MIC ratio was 
calculated. When the MBC/MIC ratio was between 1 and 2, 
the extract or pure compound was considered as bactericidal 
against the tested pathogen. When the MBC/MIC ratio was 
higher than 2, the active extract or pure compound was 
considered as bacteriostatic (Galvão et al., 2012).
Inhibitory activity against biofilm formation
The selected microorganisms were Streptococcus mutans UA 159 
and Streptococcus mutans CI. The samples of halistanol sulfate 
A (1) and of rodriguesines A (2) and B (3) that displayed broad-
spectrum antimicrobial activity against cariogenic species were 
selected based on data obtained after the MIC and MBC testing. 
Serial dilutions of the samples were added to wells of sterile 
polystyrene U-bottom microtiter plates. Final concentrations 
between 0.05 to 62.5 μg/ml of the antimicrobial agents in 0.5% 
(w/v) sucrose-containing THB medium (Toddy Hewitt Broth) 
were separately added to inocula (approximately 108 CFU/
ml) of Streptococcus mutans UA 159 or Streptococcus mutans CI. 
The microplates were incubated in 10% CO2 at 37°C for 18 
h. Biofilm growth was examined and quantified using the 
crystal violet staining method by measuring the absorbance 
at OD575 nm (O’Toole and Kolter, 1998). Briefly, after 18 h of 
incubation, the spent medium was aspirated, non-adhering 
cells were removed, the wells were washed three times with 
sterile distilled water, and the plates were dried for 45 min. The 
wells were stained with crystal violet at 1% (w/v) for 30 min, 
washed three times with distilled water and destained with 
98% ethanol (v/v) before carrying out the biofilm quantification 
in an automated microplate reader (Molecular Devices, Versa 
Max Program). Doxycycline in concentrations between 0.05 and 
1.0 μg/ml was used as a positive control. DMSO 1% (v/v) was 
used as a negative control.
The MIC of biofilm inhibition was determined as the lowest 
antimicrobial concentration capable of inhibiting biofilm 
formation without interfering with planktonic growth. Tests 
were performed in quadruplicate. Planktonic cultures in the 
wells containing biofilms at the MIC of biofilm inhibition, 
as well as 1% (v/v) DMSO vehicle, were serially diluted and 
plated on BHA (Brain Heart Agar). The number of viable cells 
(in CFU/ml) at the MIC of biofilm inhibition, relative to control, 
was measured to confirm the minimal interference of the 
antimicrobial activity on planktonic growth.
RNA extraction, synthesis of cDNA and semi-quantitative 
RT-PCR
RNA extraction of planktonic cell cultures was performed. 
Growth curves of two Streptococcus mutans strains were 
determined to establish the middle log phase (D.O. # 0.5). 
Briefly, frozen Streptococcus mutans cultures were reactivated 
in 5 ml TSB (Trypticase Soy Broth) and incubated at 37°C 
in 10% CO2 for 10 to 12 h. Standard inocula of the strains 
(approximately 108 CFU/ml, at OD550 nm) were transferred 
to tubes containing 5 ml of fresh pre-warmed BHI medium 
and incubated in the same conditions described above for the 
determination of the growth curves. The optical density (O.D.) 
was measured spectrophometrically at OD550-560 nm every 
1-2 h. Bacterial cell cultures in the middle log phase (O.D. # 
0.5) were submitted to pure compounds, doxycycline or 1% 
(v/v) DMSO control. Antimicrobial samples were evaluated for 
biofilm inhibition for 1 min (named T1) and 30 min (named 
T30) (Koo et al., 2006) with treated cells, which were collected 
by centrifugation (10,000 x g for 2 min, at 2 °C) and then frozen 
at -70 °C for RNA extraction. The experiment was conducted 
in duplicate, using two distinct cultures for each strain. RNA 
extraction of the bacterial cells was achieved using a Qiagen 
RNeasy kit according to the manufacturer’s protocol. Cells were 
lysed by incubating them with lysozyme (20 μg/ml) in a water 
bath at 37°C for 30 min and vortexing the sample in 5 min 
intervals (Duque et al., 2011). The residual DNA was removed 
with deoxyribonuclease I according to the manufacturer’s 
instructions. cDNA synthesis was performed with 24 ng of total 
RNA using a random primer Mix (20 μM) Ea1, Ea7, Es1, Es3 and 
Es8 (Chia et al., 2001) and the enzyme Super Transcript RT III 
according to the manufacturer’s protocol, with some previously 
described modifications (Kamiya et al., 2008).
The PCR experiment was performed in triplicate for each 
cDNA. One microliter of cDNA (obtained from 24 ng of RNA) 
was used as a template in the PCR (25 μl) analysis, with 50 mM 
of MgCl2, 0.3 mM of each specific primer, 200 μM of dNTPs, 1.25 
U of Taq polymerase and 10x PCR buffer, to generate amplicons 
ranging from 150-200 base pairs (Table 1). The amplicons were 
visualized on agarose gels (2% w/v) with ethidium bromide (0.3 
μg/ml). Positive controls and a 100 bp DNA ladder were included 
in each gel. Digital images were captured under ultraviolet light 
using the Gel logic 100 Imaging System (Eastman Kodak Co.). 
The curves of the amplicons per number of thermal cycles (1-60 
cycles), specific for each primer pair, were then generated to 
identify the middle of the exponential phase amplification or 
to establish the optimal number of cycles for each target gene. 
The thermal cycling parameters were as follows: 94°C for 45 
s, annealing temperature (Table 1) for 60 s, and 72°C for 60 s. 
All cDNA samples were tested with their respective 
primers for a specific target gene as well as with primers 
for the housekeeping gene 16S, a constitutively transcribed 
control gene whose expression is invariant under the used 
experimental conditions (Stipp et al., 2008). The intensities of 
the amplicons captured in the gels, using the same imaging 
system, were expressed as the relative arbitrary units of 
expression (UR). Controls for the RT-PCR included: reaction 
mixtures lacking template cDNA to effectively rule out (detect) 
the presence of contaminating DNA, and/or the formation of 
primer dimers. The positive controls included genomic DNA of 
the respective pathogenic bacterial strain. 
Statistical analysis 
Student’s t test was used to compare the significant differences 
between the planktonic growth or biofilm formation of cells 
submitted to the antimicrobial activity and the control group. 
The levels of genetic transcription variation of the treated cells 
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Primers Gene Bank Primers Sequences (5’ o 3’) Product Size Number of Cycles Annealing
gbpB_Forward
1029610
TTAATACGATTCAAGGACAA
121pb 35 52
gbpB_Reverse CTTGAAAGTGTTTGAATTTG
gtfB_Forward
1028336
AGATGGAACTTACGCTTATT
150 pb 35 52
gtfB_Reverse TCATCAAAGTATTGAACCTG
gtfC_Forward
1028343
TGATTAACATGGATAACAGG
102 pb 35 52
gtfC_Reverse CCAAACTGTTAGTGATCAGA
groEL_Forward
1029159
ACCTTGACAGGATCAATAAT
132 pb 35 52
groEL_Reverse TAAAAATGCTGGTTATGAAG
16S_Forward*
NP722374
TATCTTCCTCAATTAAACCA
181pb 27 54
16S_Reverse* TAGTTAAGATTGCCAGTGAT
* Stipp et al., 2008.
Table 1
Primer sequence, Gene Bank reference, amplicon size, and thermal conditions applied in the semi-quantitative reverse 
transcription polymerase chain reactions of known biofilm-associated genes and house-keeping gene 16S.
(after 30 min of exposure to the antimicrobial agent) and their 
respective controls (after 1 min of exposure) were applied an 
ANOVA test. The gene expression by planktonic cells submitted 
to 1% (v/v) DMSO vehicle for 30 min was also used as a control. 
The p values < 5% were considered statistically significant for 
all tests. 
Results 
Halistanol sulfate A (1), isolated from the sponge Petromica 
ciocalyptoides (Kossuga et al., 2007) and the modified 
diketopiperazines rodriguesines A (2) and B (3) isolated from 
the ascidian Didemnum sp. (Kossuga et al., 2009) (Fig. 1) inhibited 
the growth of Streptococcus mutans strains in low concentrations. 
Other bacteria growth were inhibited with higher concentrations 
of these antimicrobials agents (> 62.5 μg/ml).
Table 2 shows the MIC and MBC values, as well as the 
MBC/MIC ratio, displayed by the halistanol sulfate A (1) and 
by rodriguesines A (2) and B (3). Rodriguesines A (2) and 
B (3) were inseparable under several HPLC conditions, as 
previously reported by Kossuga et al., (2009), and were tested 
in combination. Both samples presented a broad inhibitory 
spectrum against the tested bacterial strains. Rodriguesines A 
(2) and B (3) inhibited all of the tested bacteria, with MIC values 
between 15-125 μg/ml and MBC values between 31.2-250 μg/ml. 
These modified diketopiperazines had a bactericidal effect on 
all the bacterial strains except Staphylococcus aureus ATCC 6538. 
Halistanol sulfate A showed the lowest MIC and MBC values 
when tested on Streptococcus mutans. However, its inhibitory 
effect against other species was much less potent (MIC > 125 
μg/ml) (Table 2). Therefore, it appears that halistanol sulfate A 
selectively inhibits the Streptococcus mutans pathogen at low 
concentrations, without modifying the ecological balance 
between more and less pathogenic microorganisms. The 
specificity of an oral antimicrobial agent at low concentrations 
against Streptococcus mutans is important for reducing the 
selective pressure on other bacterial species, particularly initial 
colonizers, such as Streptococcus sanguinis. Therefore, both 
halistanol sulfate A and rodriguesines A and B were selected 
for additional studies of their antibiofilm activities. 
The pathogenic Streptococcus mutans CI and Streptococcus 
mutans UA159 showed response to CV-stained biofilms greater 
than 2.0 at Omax OD575 nm in control conditions and were 
categorized as good biofilm formers (Loo et al., 2000). Fig. 1 
shows the effect of rodriguesines A and B and halistanol sulfate 
A on planktonic cells and on biofilm formation, as well as the 
MIC values of biofilm formation by Streptococcus mutans strains. 
No significant differences in the inhibition of planktonic cells 
were observed in these MIC compared to the DMSO control 
(Student’s t test, p > 0.05). As for the MIC of biofilm formation, 
we observed reductions of up to 38% in the optical density 
of planktonic cells (at Omax OD550 nm) relative to the DMSO 
vehicle (Fig. 1). There were no significant differences in the 
viable cells counts of the planktonic cultures (Student’s t test, 
p > 0.05, data not shown). These results indicate that these 
compounds present modest selectivity in their inhibition of 
biofilm formation, despite their ability to inhibit the growth 
of planktonic cells.
Halistanol sulfate A (1) showed potent antibacterial activity 
against Streptococcus mutans CI and Streptococcus mutans UA159 
strains at 3.0 μg/ml, inhibiting approximately 85.2 and 99.5% 
the biofilm formation by these species, respectively. The 
strain Streptococcus mutans UA159 was more susceptible to the 
antimicrobial activity of all tested substances in comparison 
with Streptococcus mutans CI. Biofilm formation by Streptococcus 
mutans UA159 was inhibited by 77.5 to 100%, while Streptococcus 
mutans CI biofilm formation was inhibited by 34.8 to 85.2% after 
antimicrobial treatment during 18 h.
Antimicrobial samples were evaluated on planktonic cells 
for 1 min (T1) for control samples and after 30 min (T30) 
of treatment. Diketopiperazines (2) and (3) and halistanol 
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Oral streptococci Medical pathogenic bacteria
Antimicrobial 
samples
Antimicrobial 
activities
Streptococcus 
mutans 
clinical isolate
Streptococcus 
mutans 
UA159
Streptococcus 
sobrinus 
ATCC 27607
Streptococcus
sanguinis
ATCC 15300
Escherichia
coli 
NCTC 8196
Enterococcus 
faecalis 
ATCC 14506
Staphylococcus 
aureus 
ATCC 6538
Rodriguesines
A and B
MIC 31.25 62.5 125 125 125 125 62.5
MBC 62.5 62.5 250 125 250 125 250
MBC:MIC 2 1 2 1 2 1 4
Effect bactericidal bactericidal bactericidal bactericidal bactericidal bactericidal bacteriostatic*
Halistanol
sulfate A
MIC 15 15 250 250 - 250 -
MBC 31.25 31.25 500 500 - 500 -
MBC:MIC 2 2 2 2 - 2 -
Effect bactericidal bactericidal bactericidal bactericidal - bactericidal -
The antimicrobials were considered bactericidal when the MBC:MIC ratio was between 1:1 to 2:1 and bacteriostatic if this ratio was higher than 2:1 
(Galvão et al., 2012). DMSO (1%) was used as a negative control. (*)The bacteriostatic effect of the tested samples could be bactericidal if bacterial 
inocula were used at approximately 1x105 CFU/ml, as described by CLSI (2009).
Table 2
Antimicrobial activities (values of MIC, MBC and the MBC/MIC ratio in μg/ml, bactericidal or bacteriostatic effects) of halistanol 
sulfate A and rodriguesines A/B against oral streptococci and medical pathogenic bacteria.
Figure 1 – Antimicrobial effect of rodriguesines A/B, halistanol sulfate A and doxycycline on Streptococcus mutans Clinical Isolated CI 
and Streptococcus mutans UA159 planktonic cells and biofilm formation after 18 h. The percentage of planktonic cell growth (white bars) 
or biofilm formation (gray bars) in the treated groups was calculated based on the DMSO control groups (100%). All the bars represent 
the means ± standard deviations from three independent experiments. An asterisk indicates that the cell growth between the DMSO 
and treated groups was significantly different (Student test, p < 0.05).
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sulfate A (1) affected the expression of both S. mutans UA 159 
and S. mutans CI genes involved in cell adhesion and biofilm 
formation, except the expression of groEL and 16S genes. The 
ANOVA test showed a statistically significant difference (p < 
0.05) in the levels of gtfB, gtfC and gbpB gene transcription after 
the treatment of planktonic cells in the mid-log phase with the 
antimicrobial compounds. A 15 to 85% reduction of the gene 
transcription levels relatively to the respective controls (T1) 
was observed. The gene expression was normalized relatively 
to 16S gene transcription, which showed invariable expression 
in all tested conditions (data not shown), as well as relative to 
groEL, which codes for the chaperone GroEL, a class I heat shock 
protein of Streptococcus mutans. 
Comparing DMSO 1% at T1 and at T30, we observed an 
increase of 12 to 55% (average 26.3 ± 15.3) in the transcription 
levels of biofilm-associated genes of S. mutans CI only, at T30 
(data not shown). Fig. 2 shows the percentage of gtfB, gtfC, 
gbpB and groEL transcription levels after treatment with the 
compounds 1 - 3 after 30 min. Treatment with compounds 1 - 3 
inhibited gene expression between 1.5 and 82% (51.56 ± 18.52) 
(Fig. 2). We observed a decrease in the gene expression levels 
of all tested genes, except gtfC transcription in S. mutans CI, 
which was not altered after treatment with halistanol sulfate 
A (ANOVA, p > 0.05). In addition, there were no alterations 
in the expression levels of the groEL and 16S genes after the 
antimicrobial treatments.
 The gene gbpB was more severely affected after treatment 
for 30 min with the antimicrobial compounds, with an 
expression reduction of 53 to 82% for both pathogenic 
bacterial strains. The expression of gtfB and gtfC decreased 
by approximately 1.5 to 57%, depending on the tested strain 
and the antimicrobial compounds (Fig. 2). The gbpB gene of 
Streptococcus mutans UA159 strain was inhibited (average 72.5% 
± 13.4) to a higher level than the gtf genes (average 35,8% ± 8,0). 
A higher inhibition of gtfB expression by Streptococcus mutans CI 
was observed relatively to Streptococcus mutans UA159. 
Discussion
A series of marine natural products inhibit biofilm formation 
of Pseudomonas aeruginosa, Acinetobacter baumannii, Bordetella 
bronchiseptica, Staphylococcus aureus and Streptococcus mutans 
(Huigens et al., 2007, Rogers et al., 2008, Liu et al., 2011). In 
the present investigation we verified that halistanol sulfate A 
(1), isolated from the sponge Petromica ciocalyptoides (Kossuga 
et al., 2007), and the mixture of modified diketopiperazines 
rodriguesines A (2) and B (3) isolated from an ascidian of the 
genus Didemnum (Kossuga et al., 2009), displayed low MIC values 
against Streptococcus mutans. The rodriguesines A and B had 
broad antimicrobial spectra, inhibiting both oral streptococci 
as well as  pathogenic bacteria with low MIC values. 
Diketopiperazines are dipeptides that have also been 
isolated from Gram-positive bacteria, fungi and higher 
organisms (De Carvalho and Abraham, 2012). Diketopiperazines 
are reported to modulate the LuxR-mediated quorum-sensing 
systems of Gram-negative and Gram-positive bacteria and are 
considered to influence cell-cell bacterial signaling, offering 
alternative ways to control biofilms by interfering with 
Figure 2 – The percentage of gtfB, gtfC and groEL relative expres-
sion by planktonic cells of Clinical Isolated (CI) Streptococcus mu-
tans and Streptococcus mutans UA159 after treatment for 30 min 
with rodriguesines A/B, halistanol sulfate A and doxycycline in 
the MIC of biofilm inhibition. Data were expressed relative to 
treatment with 1% DMSO for 30 min (control vehicle). An as-
terisk represents that there is no significant difference relative 
to control (ANOVA p > 0.05). The mRNA expression levels were 
calibrated using 16S rRNA. Bars represent the means ± standard 
deviations of triplicate experiments.
microbial communication (Withers et al., 2001; Abraham, 2005; 
Ryan and Dow, 2008). Streptococcus mutans LuxS affects acid and 
oxidative-stress tolerance, bacteriocin production and biofilm 
formation (Merritt et al., 2003; 2005, Wen and Burne, 2004; 
Yoshida et al., 2005; Wen et al., 2011). 
In the present investigation, the modified diketopiperazines 
rodriguesines A (2) and B (3) inhibited Streptococcus mutans 
biofilm formation and downregulated gtfB, gtfC and gbpB 
expression but did not change groEL and 16S expression. 
Diketopiperazines may act on the Lux-RS quorum-sensing 
system (Withers et al., 2001; Abraham, 2005; Ryan and Dow, 
2008), although it appears that the S. mutans gtfB, gtfC and 
gbpB genes are under the control of a distinct quorum-sensing 
system (two-component system - TCS). Inhibitors of the 
quorum-sensing TCS system and/or PknB may be important 
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for the control of S. mutans because these systems regulate 
the transcription of several virulence target genes, some of 
which have been studied in detail (Li et al., 2001; Van Der 
Ploeg Jr, 2005). However, the lack of a detailed knowledge 
of the involved cell-cell communication mechanisms has 
hindered the development of effective therapeutic strategies 
to fight bacterial infections. The increased interest in studying 
the bacterial lifestyle in biofilm formation should lead to the 
discovery of new therapeutic strategies for caries treatment 
(Bayles, 2007). 
Halistanol sulfate A inhibited biofilm formation by two 
Streptococcus mutans strains at low MIC, but it did not inhibit 
the initial colonizers represented by S. sanguinis. This activity 
profile is highly suitable because antibacterial agents that 
inhibit pathogenic bacteria and biofilms without affecting the 
healthy normal flora can be used in preventive treatments 
based on specifically targeted molecules. Agents with this 
mechanism tend to not disturb the ecological balance 
between pathogens and commensal residents in the oral 
cavity (Liu et al., 2011). 
Halistanol sulfates A-E were first described as antifungal 
and antithrombin agents (Kanazawa et al., 1992). Previously 
it has been observed that halistanol sulfate A affects 
Staphylococcus aureus cells, possibly via a disruption membrane 
mechanism (Marinho et al., 2012). Sterol sulfates related to 
halistanol trisulfate A may act as detergents, inhibiting the 
growth of Gram-positive bacteria without affecting Gram-
negative bacteria, possibly via a membranolytic mechanism 
and may also inhibit bacterial protein-tyrosine kinases (Slate, 
et al., 1994).
Streptococcus mutans CI showed higher resistance to the 
antibiofilm action of small-molecules than S. mutans UA159. 
The resistance mechanisms or intermediary resistance 
to antimicrobials agents are known to be variable among 
bacterial genotypes. The existence of a high diversity of S. 
mutans genotypes in human oral cavities (Kamiya et al., 2005) 
suggests that such antibacterial small-molecules should be 
tested against different strains with possible distinct resistance 
phenotype/genotypes to antimicrobial agents. The mechanisms 
controlling the expression of the gtfB, gtfC and gbpB virulence 
genes are strain-specific, illustrating the genetic diversity of S. 
mutans (Stipp et al., 2008). Such genotypic variation may have 
further implications in the selection of therapeutic targets to 
control this cariogenic bacterium.
After antimicrobial treatment with halistanol, rodriguesines 
or doxycycline, there was a significant reduction in the 
Streptococcus mutans biofilm formation, although there were 
no alterations in the groEL expression levels. The gene groEL 
codes for a chaperone, that has essential roles in cellular 
metabolism by assisting in the folding of newly synthesized 
or denatured proteins, as well as in the assembly, transport, 
and degradation of cellular proteins (Bukau and Horwich, 1998). 
In S. mutans, GroEL is classified as a class I heat shock protein 
as well is the chaperone DnaK. Lemos et al. (2007), showed 
that the down-regulation of dnaK and groEL reduced S. mutans 
biofilm formation and acid tolerance, suggesting that the 
regulatory response by S. mutans to environmental stresses for 
the development and maturation of a biofilm has a significant 
influence on the biofilm structure. Our data suggest that groEL 
expression is not essential for the development of S. mutans 
biofilms because groEL is not a target gene of halistanol sulfate 
A and rodriguesines. These antimicrobial agents inhibited 
biofilm formation by the down regulation of gtfB / gtfC and 
gbpB, which codes for a water-insoluble glucan matrix and 
increases the interaction between S. mutans and glucans of 
the matrix.  
The evaluation of natural products against different 
Streptococcus mutans genotypes is important for establishing 
the antibacterial effectiveness of these substances and for 
elucidating their effects on the selective pressure of possible 
S. mutans genotypes that are resistant to antimicrobial agents. 
The results presented herein illustrate the potential of marine 
secondary metabolites to act as antibacterial agents against 
S. mutans with distinct modes-of-action. Further studies are 
necessary to clarify the mechanisms-of-action of rodriguesines 
and halistanol sulfate A, their effects on the regulation of other 
S. mutans virulence genes and/or S. mutans quorum sensing 
signaling pathways, and their respective species-specific 
antibacterial activities in multi-species biofilm models, both 
in vitro and in vivo, associated with transcriptome and/or 
proteome analyses.
Conclusion
The modified diketopiperazines rodriguesines A and B as 
well as halistanol sulfate A displayed inhibitory effects 
on biofilm formation by Streptococcus mutans and down 
regulate the expression of the gtfB, gtfC and gbpB genes. 
The antimicrobial properties of halistanol sulfate A suggest 
that it may be useful in the development of new drug 
candidates for anti-Streptococcus mutans therapy because it 
selectively inhibits biofilm formation by S. mutans strains at 
low concentrations, not affecting initial buccal colonizing 
species such as S. sanguinis. 
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